Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Rna Diagnostics Inc Company Overview 4
Rna Diagnostics Inc Company Snapshot 4
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Rna Diagnostics Inc – Pipeline Analysis Overview 6
Rna Diagnostics Inc – Key Facts 6
Rna Diagnostics Inc – Major Products and Services 7
Rna Diagnostics Inc Pipeline Products by Development Stage 8
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10
Rna Diagnostics Inc Pipeline Products Overview 11
RNA Disruption Assay – Breast Cancer 11
RNA Disruption Assay – Breast Cancer Product Overview 11
RNA Disruption Assay – Breast Cancer Clinical Trial 12
RNA Disruption Assay – Head & Neck Cancer 13
RNA Disruption Assay – Head & Neck Cancer Product Overview 13
RNA Disruption Assay – Ovarian Cancer 14
RNA Disruption Assay – Ovarian Cancer Product Overview 14
RNA Disruption Assay – Rectal Cancer 15
RNA Disruption Assay – Rectal Cancer Product Overview 15
RNA Disruption Assay – Sarcoma 16
RNA Disruption Assay – Sarcoma Product Overview 16
Rna Diagnostics Inc – Key Competitors 17
Rna Diagnostics Inc – Key Employees 18
Rna Diagnostics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Rna Diagnostics Inc, Recent Developments 20
May 17, 2018: Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test 20
Apr 27, 2018: First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA in Primary Breast Cancer 21
Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board 22
Jun 14, 2017: Rna Diagnostics Launches BREVITY – International Validation Trial of RDA in Breast Cancer 22
Sep 15, 2016: Further Evidence RDA May Predict Clinical Outcome Of Chemotherapy In Journal Of The National Cancer Institute 23
Apr 01, 2016: Rna Diagnostics appoints Dr. Jeremy Bridge-Cook President and CEO 24
Feb 18, 2016: Paul Lucas joins the Board of Directors at Rna Diagnostics 24
May 30, 2013: Rna Diagnostics Selected To Participate In Excite Program To Evaluate RNA Disruption Assay 25
Feb 19, 2013: Rna Diagnostics Gets $462,500 Grant From FedDev Ontario For RNA Disruption Assay 25
Nov 02, 2012: Denis Ho joins Rna Diagnostics’ Board of Directors 25
Appendix 27
Methodology 27
About GlobalData 30
Contact Us 30
Disclaimer 30
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Rna Diagnostics Inc Pipeline Products by Equipment Type 5
Rna Diagnostics Inc Pipeline Products by Indication 5
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 5
Rna Diagnostics Inc, Key Facts 6
Rna Diagnostics Inc, Major Products and Services 7
Rna Diagnostics Inc Number of Pipeline Products by Development Stage 8
Rna Diagnostics Inc Pipeline Products Summary by Development Stage 9
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10
Rna Diagnostics Inc Ongoing Clinical Trials Summary 10
RNA Disruption Assay - Breast Cancer - Product Status 11
RNA Disruption Assay - Breast Cancer - Product Description 11
RNA Disruption Assay - Breast Cancer - Breast Cancer Response Evaluation for Individualized Therapy: BREVITY 12
RNA Disruption Assay - Head & Neck Cancer - Product Status 13
RNA Disruption Assay - Head & Neck Cancer - Product Description 13
RNA Disruption Assay - Ovarian Cancer - Product Status 14
RNA Disruption Assay - Ovarian Cancer - Product Description 14
RNA Disruption Assay - Rectal Cancer - Product Status 15
RNA Disruption Assay - Rectal Cancer - Product Description 15
RNA Disruption Assay - Sarcoma - Product Status 16
RNA Disruption Assay - Sarcoma - Product Description 16
Rna Diagnostics Inc, Key Employees 18
Rna Diagnostics Inc, Other Locations 19
Glossary 29
List of Figures
Rna Diagnostics Inc Pipeline Products by Equipment Type 5
Rna Diagnostics Inc Pipeline Products by Development Stage 8
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10